South Korea · Hospital & Health Care
Medical Devices
Hospital & Health Care
Biotechnology
Healthcare
Access Bio Korea was established as a 100% subsidiary of Access Bio in the United States. Currently, rapid diagnostic kits are in the spotlight due to the global COVID-19 crisis, and we produce antibody/antigen identification diagnostic kits for COVID-19 as our main item. It also produces items from Wells Bio Co., Ltd., a subsidiary in Korea, and is sold worldwide in Asia, the Middle East, and Europe. In addition to products related to COVID-19, we produce Flu A&B and Dengue products as our main items. Our factory has acquired GMP and ISO and is constantly striving to improve productivity and quality.
2017
Founded
Hospital & Health Care
Industry
South Korea
Location
7,248,735
Ranking
4 employees
Size

Get full access to view complete information
